Relation of B-type natriuretic peptide (BNP) and infarct size as assessed by contrast-enhanced MRI

International Journal of Cardiology

Volumn 144, Issue 1, 2010, Pages 53-58

  Bruder, Oliver ^a   Jensen, Christoph ^a   Jochims, Markus ^a   Farazandeh, Mani ^a   Barkhausen, Joerg ^b   Schlosser, Thomas ^b   Sabin, Georg V ^a   Hunold, Peter ^b  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acute ST segment elevation myocardial infarction; B type natriuretic peptide; Cardiac magnetic resonance imaging; Delayed enhancement

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EDETIC ACID;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

BIOLOGICAL MARKERS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 77957863455     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.139     Document Type: Article

References (48)

1. B.M. Cheung, and C.R. Kumana Natriuretic peptides-relevance in cardiovascular disease Jama 280 1998 1983 1984
2. K. Maeda, T. Tsutamoto, A. Wada, T. Hisanaga, and M. Kinoshita Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825 832
3. H. Yasue, M. Yoshimura, and H. Sumida Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
4. S.K. James, B. Lindahl, and A. Siegbahn N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy Circulation 108 2003 275 281
5. A.M. Richards, M.G. Nicholls, and E.A. Espiner B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
6. J.A. de Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
7. J.L. Mega, D.A. Morrow, and J.A. De Lemos B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy J Am Coll Cardiol 44 2004 335 339
8. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
9. D.A. Morrow, J.A. de Lemos, and M.A. Blazing Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease Jama 294 2005 2866 2871
10. D.A. Morrow, J.A. de Lemos, and M.S. Sabatine Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol 41 2003 1264 1272
11. R. Berger, M. Huelsman, and K. Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
12. R.S. Gardner, F. Ozalp, A.J. Murday, S.D. Robb, and T.A. McDonagh N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure Eur Heart J 24 2003 1735 1743
13. B.A. Groenning, I. Raymond, P.R. Hildebrandt, J.C. Nilsson, M. Baumann, and F. Pedersen Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population Heart 90 2004 297 303
14. T. Tsutamoto, A. Wada, and K. Maeda Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
15. T. Mueller, A. Gegenhuber, B. Dieplinger, W. Poelz, and M. Haltmayer Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples Clin Chem Lab Med 42 2004 942 944
16. S.M. Nidorf, S.C. Siu, G. Galambos, A.E. Weyman, and M.H. Picard Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction J Am Coll Cardiol 21 1993 683 691
17. J.S. Hochman, and H. Choo Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage Circulation 75 1987 299 306
18. C.J. Lavie, J.H. O'Keefe Jr., J.H. Chesebro, I.P. Clements, and R.J. Gibbons Prevention of late ventricular dilatation after acute myocardial infarction by successful thrombolytic reperfusion Am J Cardiol 66 1990 31 36
19. K.M. Choi, R.J. Kim, G. Gubernikoff, J.D. Vargas, M. Parker, and R.M. Judd Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function Circulation 104 2001 1101 1107
20. K.C. Wu, E.A. Zerhouni, and R.M. Judd Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
21. A.M. Beek, H.P. Kuhl, and O. Bondarenko Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction J Am Coll Cardiol 42 2003 895 901
22. V. Hombach, O. Grebe, and N. Merkle Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging Eur Heart J 26 2005 549 557
23. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group Diabetes 28 1979 1039 1057
24. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
25. P.K. Whelton Epidemiology of hypertension Lancet 344 1994 101 106
26. O. Bruder, F. Breuckmann, and C. Jensen Prognostic impact of contrast-enhanced CMR early after acute ST Segment Elevation Myocardial Infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen" Herz 33 2008 136 142
27. O. Bruder, C.K. Naber, and B. Grosch New health care delivery model in cardiology-Myocardial Infarction Network Essen Herz 32 2007 630 634
28. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Int J Cardiovasc Imaging 18 2002 539 542
29. B. Sievers, S. Kirchberg, M. Addo, A. Bakan, B. Brandts, and H.J. Trappe Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP J Cardiovasc Magn Reson 6 2004 855 863
30. M.C. Dulce, G.H. Mostbeck, K.K. Friese, G.R. Caputo, and C.B. Higgins Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data Radiology 188 1993 371 376
31. S.J. Lester, E.W. Ryan, N.B. Schiller, and E. Foster Best method in clinical practice and in research studies to determine left atrial size Am J Cardiol 84 1999 829 832
32. E. Morita, H. Yasue, and M. Yoshimura Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 88 1993 82 91 (Pubitemid 23195436)
33. N. Arakawa, M. Nakamura, H. Aoki, and K. Hiramori Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction J Am Coll Cardiol 27 1996 1656 1661
34. A.M. Richards, M.G. Nicholls, and T.G. Yandle Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction Circulation 97 1998 1921 1929
35. T. Omland, A. Aakvaag, and V.V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
36. S. Talwar, I.B. Squire, and P.F. Downie Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction Eur Heart J 21 2000 1514 1521
37. N. Arakawa, M. Nakamura, H. Aoki, and K. Hiramori Relationship between plasma level of brain natriuretic peptide and myocardial infarct size Cardiology 85 1994 334 340
38. K. Nakagawa, K. Umetani, and D. Fujioka Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction Circ J 68 2004 923 927
39. A. Cochet, M. Zeller, and Y. Cottin The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction Eur J Heart Fail 6 2004 555 560
40. R.J. Kim, D.S. Fieno, and T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1999 1992 2002
41. B.P. Paelinck, C.J. Vrints, and J.J. Bax Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging Am J Cardiol 97 2006 1146 1150
42. A. Vorlat, M.J. Claeys, J.M. Bosmans, V. Van Hoof, and C.J. Vrints B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction Int J Cardiol 114 2007 46 49
43. M. Grabowski, K.J. Filipiak, and L.A. Malek Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty Int J Cardiol 115 2007 386 390
44. R. Nijveldt, A.M. Beek, and A. Hirsch Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury J Am Coll Cardiol 52 2008 181 189 (Pubitemid 351915778)
45. R. Beinart, V. Boyko, and E. Schwammenthal Long-term prognostic significance of left atrial volume in acute myocardial infarction J Am Coll Cardiol 44 2004 327 334
46. M. Yoshimura, H. Yasue, and K. Okumura Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure Circulation 87 1993 464 469
47. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
48. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150